Merck CFO sells 63,000 shares of stock
The Associated Press reports that executive vice president and chief financial officer of drug developer Merck & Co. sold 63,000 shares of common stock, according to a Securities and Exchange Commission filing. In a Form 4 filed with the SEC, Judy C. Lewent reported she sold the shares for $50.10 to $51.22 apiece last Wednesday. Insiders file Form 4s with the SEC to report transactions in their companies'' shares. Open market purchases and sales must be reported within two business days of the transaction.